Role of prostaglandins in the activity of some cardiovascular drugs.
Masotti
G
G
D000804:Angiotensin II / Q000096:biosynthesis; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use; D015232:Dinoprostone; D004176:Dipyridamole / Q000627:therapeutic use*; D011464:Epoprostenol / Q000096:biosynthesis; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007705:Kinins / Q000097:blood; D005996:Nitroglycerin / Q000627:therapeutic use*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000502:physiology*; D011458:Prostaglandins E / Q000097:blood; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D000959:Antihypertensive Agents; D007705:Kinins; D011453:Prostaglandins; D011458:Prostaglandins E; D000804:Angiotensin II; D004176:Dipyridamole; D002216:Captopril; D011464:Epoprostenol; D007703:Peptidyl-Dipeptidase A; D013930:Thromboxane-A Synthase; D005996:Nitroglycerin; D015232:Dinoprostone; D001241:Aspirin; D007213:Indomethacin